Martine A. Rothblatt, Director: United Therapeutics UTHR Sell · Filed 24/05/20

Trade details

Type: Insider sale
Amount: $577,401.5
Shares · price: 2,110 sh · $273.65 a share
Held after: 663 sh
Stock: United Therapeutics UTHR
Person: Martine A. RothblattDirector
Trade date: 24/05/17
Filed: 24/05/20
Days to filing: 3 days

Sold 76.1% of holdings

Share of holding sold: 76.1%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 24/04/17~24/06/16

Martine A. Rothblatt's recent trades

Martine A. RothblattChairperson & CEO
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 plan
United Therapeutics
UTHR
$775.2K
1,346 sh
$775.2K
Filed 10/02
Traded 10/01
Martine A. RothblattChairperson & CEO
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 plan
United Therapeutics
UTHR
$537.5K
930 sh
$537.5K
Filed 10/02
Traded 10/01
Martine A. RothblattChairperson & CEO
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 plan
United Therapeutics
UTHR
$501.3K
864 sh
$501.3K
Filed 10/02
Traded 10/01
Martine A. RothblattChairperson & CEO
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 plan
United Therapeutics
UTHR
$477.2K
830 sh
$477.2K
Filed 10/02
Traded 10/01
Martine A. RothblattChairperson & CEO
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 plan
United Therapeutics
UTHR
$446.5K
774 sh
$446.5K
Filed 10/02
Traded 10/01

Martine A. Rothblatt, Director — sold $577.4K of United Therapeutics UTHR · 76.1% of holdings · 10b5-1 plan | Whalegun